ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $328,578 | +6.0% | 16,036 | +2.8% | 0.00% | 0.0% |
| Q2 2023 | $309,992 | +5.8% | 15,601 | -8.8% | 0.00% | 0.0% |
| Q1 2023 | $293,077 | -2.9% | 17,109 | +11.0% | 0.00% | 0.0% |
| Q4 2022 | $301,691 | +62.2% | 15,416 | +32.6% | 0.00% | +50.0% |
| Q3 2022 | $186,000 | +19.2% | 11,629 | +2.4% | 0.00% | 0.0% |
| Q2 2022 | $156,000 | -6.0% | 11,352 | +8.6% | 0.00% | +100.0% |
| Q1 2022 | $166,000 | -25.9% | 10,452 | +1.7% | 0.00% | -50.0% |
| Q4 2021 | $224,000 | -27.7% | 10,273 | -0.8% | 0.00% | -33.3% |
| Q3 2021 | $310,000 | -29.1% | 10,361 | +4.9% | 0.00% | -25.0% |
| Q2 2021 | $437,000 | +11.5% | 9,874 | +11.7% | 0.00% | +33.3% |
| Q1 2021 | $392,000 | -18.8% | 8,843 | +0.4% | 0.00% | -25.0% |
| Q4 2020 | $483,000 | +131.1% | 8,808 | -3.8% | 0.00% | +100.0% |
| Q3 2020 | $209,000 | – | 9,154 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |